World's Best Scientists 2026 revealed!
William V. Bobo

William V. Bobo

D-Index & Metrics

Social Sciences and Humanities

D-Index
46
Citations
7729
World Ranking
3668
National Ranking
1757

William V. Bobo publication distribution in Social Sciences and Humanities in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Social Sciences and Humanities in 2026. The highlighted bar marks where William V. Bobo sits on this spectrum.

44–53 publications: 28 scientists 54–63 publications: 61 scientists 64–73 publications: 161 scientists 74–83 publications: 225 scientists 84–93 publications: 301 scientists 94–103 publications: 390 scientists 104–113 publications: 406 scientists 114–123 publications: 474 scientists 124–133 publications: 453 scientists 134–143 publications: 434 scientists 144–153 publications: 407 scientists 154–163 publications: 411 scientists 164–173 publications: 391 scientists 174–183 publications: 313 scientists 184–193 publications: 319 scientists 194–203 publications: 304 scientists 204–213 publications: 285 scientists 214–223 publications: 246 scientists 224–233 publications: 213 scientists 234–243 publications: 170 scientists 244–253 publications: 167 scientists 254–263 publications: 162 scientists 264–273 publications: 138 scientists 274–283 publications: 138 scientists 284–293 publications: 113 scientists 294–303 publications: 106 scientists 304–313 publications: 95 scientists 314–323 publications: 101 scientists 324–333 publications: 81 scientists 334–343 publications: 69 scientists 344–353 publications: 56 scientists 354–363 publications: 36 scientists 364–373 publications: 42 scientists 374–383 publications: 41 scientists 384–393 publications: 44 scientists 394–403 publications: 27 scientists 404–413 publications: 30 scientists 414–423 publications: 20 scientists 424–433 publications: 29 scientists 434–443 publications: 29 scientists 444–453 publications: 25 scientists 454–463 publications: 19 scientists 464–473 publications: 21 scientists 474–483 publications: 11 scientists 484–493 publications: 17 scientists 494–503 publications: 7 scientists 504–513 publications: 6 scientists 514–523 publications: 12 scientists 524–533 publications: 10 scientists 534–543 publications: 7 scientists 544–553 publications: 6 scientists 554–563 publications: 12 scientists 564–569 publications: 8 scientists 570+ publications: 100 scientists
44 publications 570+

This scientist: 178 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 570 publications or more.

William V. Bobo D-index placement in Social Sciences and Humanities in 2026

The chart shows the D-index (discipline H-index) distribution of Social Sciences and Humanities scientists ranked by Research.com in 2026. The highlighted bar marks where William V. Bobo sits on this spectrum.

30 D-Index: 177 scientists 31 D-Index: 210 scientists 32 D-Index: 222 scientists 33 D-Index: 188 scientists 34 D-Index: 181 scientists 35 D-Index: 243 scientists 36 D-Index: 261 scientists 37 D-Index: 272 scientists 38 D-Index: 278 scientists 39 D-Index: 300 scientists 40 D-Index: 297 scientists 41 D-Index: 308 scientists 42 D-Index: 313 scientists 43 D-Index: 300 scientists 44 D-Index: 269 scientists 45 D-Index: 260 scientists 46 D-Index: 228 scientists 47 D-Index: 251 scientists 48 D-Index: 203 scientists 49 D-Index: 186 scientists 50 D-Index: 187 scientists 51 D-Index: 166 scientists 52 D-Index: 138 scientists 53 D-Index: 141 scientists 54 D-Index: 131 scientists 55 D-Index: 137 scientists 56 D-Index: 109 scientists 57 D-Index: 129 scientists 58 D-Index: 95 scientists 59 D-Index: 105 scientists 60 D-Index: 106 scientists 61 D-Index: 86 scientists 62 D-Index: 94 scientists 63 D-Index: 77 scientists 64 D-Index: 79 scientists 65 D-Index: 59 scientists 66 D-Index: 68 scientists 67 D-Index: 51 scientists 68 D-Index: 49 scientists 69 D-Index: 40 scientists 70 D-Index: 43 scientists 71 D-Index: 40 scientists 72 D-Index: 50 scientists 73 D-Index: 46 scientists 74 D-Index: 43 scientists 75 D-Index: 45 scientists 76 D-Index: 45 scientists 77 D-Index: 30 scientists 78 D-Index: 25 scientists 79 D-Index: 31 scientists 80 D-Index: 29 scientists 81 D-Index: 18 scientists 82 D-Index: 21 scientists 83 D-Index: 26 scientists 84 D-Index: 15 scientists 85 D-Index: 15 scientists 86 D-Index: 19 scientists 87 D-Index: 19 scientists 88 D-Index: 12 scientists 89 D-Index: 7 scientists 90 D-Index: 19 scientists 91 D-Index: 20 scientists 92 D-Index: 13 scientists 93 D-Index: 9 scientists 94 D-Index: 13 scientists 95 D-Index: 8 scientists 96 D-Index: 7 scientists 97 D-Index: 6 scientists 98 D-Index: 6 scientists 99 D-Index: 6 scientists 100+ D-Index: 97 scientists
30 D-Index 100+

This scientist: 46 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 100 D-Index or more.

Overview

William V. Bobo is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medicine, with a particular focus on psychiatry and mental health. Their research spans multiple subfields including pharmacology, psychiatry and mental health, experimental and cognitive psychology, biological psychiatry, and public health, environmental and occupational health.

The primary areas of study in their work include treatment of major depression, tryptophan and brain disorders, mental health research topics, electroconvulsive therapy studies, maternal mental health during pregnancy and postpartum, bipolar disorder and treatment, and functional brain connectivity studies.

Recent notable publications by William V. Bobo include:

  • Association of Depression and Anxiety With the Accumulation of Chronic Conditions, 2022, JAMA Network Open
  • Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects, 2020, JAMA Psychiatry
  • The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study, 2020, Epidemiology and Psychiatric Sciences
  • Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication, 2021, Translational Psychiatry
  • Implementing the US Department of Health and Human Services definition of multimorbidity: a comparison between billing codes and medical record review in a population-based sample of persons 40-84 years old, 2021, BMJ Open

William V. Bobo frequently collaborates with several coauthors, including:

  • Arjun P. Athreya
  • Paul E. Croarkin
  • Mark A. Frye
  • Madhukar H. Trivedi
  • Taryn L. Mayes

Their work appears regularly in various publication venues, notably:

  • Journal of Child and Adolescent Psychopharmacology
  • Biological Psychiatry
  • Journal of Affective Disorders
  • The Journal of Clinical Psychiatry
  • BMJ Open

This profile shows William V. Bobo's involvement in interdisciplinary research within medicine and mental health, marked by contributions to both clinical and experimental studies. Their collaborations and frequent publication venues reflect a focus on psychiatric pharmacology and mental health treatment research.

Best Publications

  • Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations

    Pauline M. Maki;Susan G. Kornstein;Hadine Joffe;Joyce T. Bromberger

  • Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity.

    Jennifer L St Sauver;Cynthia M Boyd;Brandon R Grossardt;William V Bobo

  • Prevalence of Multimorbidity in a Geographically Defined American Population: Patterns by Age, Sex, and Race/Ethnicity

    Walter A. Rocca;Cynthia M. Boyd;Brandon R. Grossardt;William V. Bobo

  • Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth

    William V. Bobo;William O. Cooper;C. Michael Stein;Mark Olfson

  • The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)−9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS)

    Peter J. Na;Satyanarayana R. Yaramala;Jihoon A. Kim;Hyelee Kim

  • Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.

    Herbert Y. Meltzer;William V. Bobo;Isaac F. Nuamah;Rosanne Lane

  • Antidepressant Discontinuation Syndrome

    Christopher H. Warner;William Bobo;Carolynn M. Warner;Sara Reid

  • A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia

    Herbert Y Meltzer;William V Bobo;Ajanta Roy;Karu Jayathilake

  • Association of Depression and Anxiety With the Accumulation of Chronic Conditions

    Unknown

  • Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study

    J. Westman;S. V. Eriksson;M. Gissler;J. Hällgren

  • Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001–2007: a population-based study of 585,615 deliveries

    Sengwee Toh;Qian Li;T. Craig Cheetham;William O. Cooper

  • KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.

    William V. Bobo;Jennifer L. Vande Voort;Paul E. Croarkin;Jonathan G. Leung

  • Increasing pregnancy-related use of prescribed opioid analgesics

    Richard A. Epstein;William V. Bobo;Peter R. Martin;James A. Morrow

  • Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)

    Louisa G. Sylvia;Richard C. Shelton;David E. Kemp;Emily E. Bernstein

  • Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta‐analysis

    M. L. Prieto;A. B. Cuéllar-Barboza;A. B. Cuéllar-Barboza;W. V. Bobo;V. L. Roger

  • TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

    M Gupta;D Neavin;D Liu;J Biernacka

  • Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.

    Kayla N. Anderson;Jennifer N. Lind;Jennifer N. Lind;Regina M. Simeone;William V. Bobo

  • Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.

    Louisa G. Sylvia;Edward S. Friedman;James H. Kocsis;Emily E. Bernstein

  • Continuation phase intravenous ketamine in adults with treatment-resistant depression

    Jennifer L. Vande Voort;Robert J. Morgan;Simon Kung;Keith G. Rasmussen

  • Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication

    Arjun P. Athreya;Arjun P. Athreya;Drew Neavin;Tania Carrillo-Roa;Michelle Skime

  • Concise review for physicians and other clinicians: postpartum depression.

    William V. Bobo;Barbara P. Yawn

  • Comparative mortality risks of antipsychotic medications in community-dwelling older adults.

    T. Gerhard;K. Huybrechts;M. Olfson;S. Schneeweiss

  • Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

    Andrew A. Nierenberg;Susan L. McElroy;Edward S. Friedman;Terence A. Ketter

Frequent Co-Authors

Richard C. Shelton
Richard C. Shelton University of Alabama at Birmingham
Mark A. Frye
Mark A. Frye University of California, Los Angeles
Susan L. McElroy
Susan L. McElroy University of Cincinnati Medical Center
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Louisa G. Sylvia
Louisa G. Sylvia Harvard University
Mauricio Tohen
Mauricio Tohen University of New Mexico
Terence A. Ketter
Terence A. Ketter Stanford University
Thilo Deckersbach
Thilo Deckersbach Harvard University
Michael E. Thase
Michael E. Thase University of Pennsylvania
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in social sciences and humanities continues to grow, students are seeking flexible and cost-effective routes to enter these fields. Online education offers a variety of pathways, from undergraduate to graduate levels, that cater to diverse professional goals and individual needs.

Many students are choosing 1 year graduate programs to quickly advance their careers while gaining specialized knowledge. For those looking to earn their undergraduate degree faster, enrolling in an accelerated bachelor's degree can save both time and tuition costs.

Social services remain a popular and rewarding field. Pursuing online msw programs enables working adults to qualify for advanced positions in social work, while bcba programs online support those seeking expertise in behavioral analysis and therapy.

With these online options, students can balance commitments and tailor their education to match their career pathways in social sciences and humanities.

Best Scientists Citing William V. Bobo

Trending Scientists

Recently Published Articles